Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

13.30
Delayed Data
As of 3:59pm ET
 -0.05 / -0.37%
Today’s Change
7.02
Today|||52-Week Range
18.50
+9.92%
Year-to-Date
No recent news for Epizyme Inc.

Today’s Trading

Previous close13.35
Today’s open13.35
Day’s range13.00 - 13.68
Volume468,871
Average volume (3 months)652,824
Market cap$779.1M
Dividend yield--
Data as of 3:59pm ET, 07/24/2017

Growth & Valuation

Earnings growth (last year)+41.87%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+212.77%
P/E ratioNM
Price/Sales86.33
Price/Book3.84

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...-0.05-0.53%
RTRXRetrophin Inc+0.50+2.53%
CHRSCoherus BioSciences ...+0.20+1.47%
FPRXFive Prime Therapeut...+1.16+3.89%
Data as of 3:59pm ET, 07/24/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$8.0M
Annual profit (last year)-$110.2M
Net profit margin-1,376.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts